Retractable Technologies (RVP) Income from Continuing Operations (2010 - 2026)
Retractable Technologies' (RVP) quarterly Income from Continuing Operations came in at $2.2 million in Q2 2026, up 2658.29% on a YoY basis from $81128.6 in Q2 2025, and up 166.98% quarter-over-quarter from -$3.3 million in Q1 2026.
Analysis
Retractable Technologies (RVP) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Retractable Technologies (RVP) has reported Income from Continuing Operations for 17 consecutive years, with $2.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Income from Continuing Operations rose 2658.29% year-over-year to $2.2 million; the trailing twelve-month figure through Jun 2026 stood at -$211304.0 (up 97.58% YoY), and the FY2025 full-year result was -$9.7 million, up 18.43% from the prior year.
- Income from Continuing Operations advanced to $2.2 million in Q2 2026 per RVP's latest filing, from -$3.3 million in the prior quarter.
- Across five years, Income from Continuing Operations topped out at $7.6 million in Q1 2022 and bottomed at -$14.2 million in Q2 2024.
- Historically, Income from Continuing Operations has averaged -$959518.0 across 5 years, with a median of $149050.5 in 2023.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations soared 5269.2% in 2024, then plunged 2545.53% in 2025.
- Over 5 years, Income from Continuing Operations stood at $3.1 million in 2022, then sank by 102.38% to -$72946.0 in 2023, then jumped by 5269.2% to $3.8 million in 2024, then tumbled by 86.19% to $520729.0 in 2025, then soared by 329.74% to $2.2 million in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered $2.2 million, -$3.3 million, and $520729.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 49.48 Bn | 48.62 Bn | 2.32 Bn | 452.00 Mn |
| 2 | Medline | 29.24 Bn | 26.56 Bn | 2.22 Bn | 139.00 Mn |
| 3 | West Pharmaceutical Services | 23.94 Bn | 23.51 Bn | 329.20 Mn | 147.90 Mn |
| 4 | Baxter International | 12.66 Bn | 10.51 Bn | 1.03 Bn | 135.00 Mn |
| 5 | Stevanato Group S.p.A | 5.51 Bn | 5.40 Bn | 100.91 Mn | 26.68 Mn |
| 6 | Acme United | 233.67 Mn | 228.63 Mn | 26.69 Mn | 5.05 Mn |
| 7 | Rockwell Medical | 31.87 Mn | 7.07 Mn | 3.24 Mn | -1.30 Mn |
| 8 | Retractable Technologies | 21.39 Mn | -18.48 Mn | 190,852.00 | 2.24 Mn |
| 9 | United Health Products | 9.09 Mn | 9.06 Mn | - | -217,306.00 |
| 10 | Cuprina Holdings (Cayman) | 7.45 Mn | 4.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.24 Mn |
| Mar 31, 2026 | -3.34 Mn |
| Dec 31, 2025 | 520,729.00 |
| Sep 30, 2025 | 371,047.00 |
| Jun 30, 2025 | -87,471.00 |
| Mar 31, 2025 | -10.50 Mn |
| Dec 31, 2024 | 3.77 Mn |
| Sep 30, 2024 | -1.92 Mn |
| Jun 30, 2024 | -14.16 Mn |
| Mar 31, 2024 | 429,384.00 |
| Dec 31, 2023 | -72,946.00 |
| Sep 30, 2023 | -4.06 Mn |
| Jun 30, 2023 | -3.87 Mn |
| Mar 31, 2023 | 990,972.00 |
| Dec 31, 2022 | 3.07 Mn |
| Sep 30, 2022 | 5.39 Mn |
| Jun 30, 2022 | -3.64 Mn |
| Mar 31, 2022 | 7.62 Mn |
| Dec 31, 2021 | 11.69 Mn |
| Sep 30, 2021 | 6.52 Mn |